RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Vilazodone Effective and Safe in Major Depressive Disorder
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 8
SP 13
OP 14
DO 10.1177/155989771408004
UL http://mdc.sagepub.com/content/14/8/13.abstract
AB A multicenter, randomized, double-blind, placebo-controlled trial involving more than 1100 patients with major depressive disorder has affirmed the efficacy and safety of vilazodone 40 mg/day and indicated the acceptability of a dose of 20 mg/day [APA 2014 (poster NR6-103)].